Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01491737
Title A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer (PERTAIN)
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors Hoffmann-La Roche
Indications

Her2-receptor positive breast cancer

Therapies

Anastrozole

Letrozole

Trastuzumab

Pertuzumab + Trastuzumab

Age Groups: senior | adult
Covered Countries USA | ITA | GBR | FRA | ESP

Additional content available in CKB BOOST